NEWS
Supreme Court issues fresh notice to Anil Ambani, ADAG in PIL alleging ₹1.5 lakh crore fraud
By Axel Miller | 23 Jan 2026
The Supreme Court issued fresh notice to Anil Ambani and ADAG in a PIL alleging a ₹1.5 lakh crore banking fraud and sought sealed status reports from the CBI and ED.
India targets $1.3 trillion goods exports by 2035 with deregulation-led manufacturing push
By Cygnus | 23 Jan 2026
India aims to triple goods exports to $1.3 trillion by 2035 through deregulation-led manufacturing reforms, with modest funding for 30 hubs and grants for sunrise sectors.
India cancels more South American soy oil imports as rupee slump widens price gap
By Axel Miller | 23 Jan 2026
India canceled more South American soybean oil cargoes after the rupee weakened, widening the cost gap with local supplies and pushing buyers toward cheaper palm oil.
Intel warns of AI chip supply crunch; shares slide 13% on weak Q1 2026 forecast
By Axel Miller | 23 Jan 2026
Intel shares fell 13% after hours after the chipmaker forecast weak Q1 2026 results and warned supply constraints are limiting AI data center chip shipments.
IndiGo Launches Non-Stop Flights to Athens From Mumbai and Delhi
By Cygnus | 23 Jan 2026
IndiGo launched non-stop flights to Athens from Mumbai on Jan 23 and will start Delhi services on Jan 24, expanding its Europe network using the Airbus A321XLR.
Trump Sues JPMorgan and CEO Jamie Dimon for $5 Billion Over Alleged Political ‘Debanking’
By Axel Miller | 23 Jan 2026
Trump filed a $5 billion lawsuit against JPMorgan and CEO Jamie Dimon in Florida, alleging politically motivated debanking after January 6. JPMorgan calls it without merit.
Micron’s $2.75 Billion Gujarat Chip Facility to Start Commercial Operations by End-February
By Cygnus | 23 Jan 2026
Micron’s $2.75 billion Gujarat semiconductor ATMP facility in Sanand is expected to begin commercial operations by end-February 2026, Ashwini Vaishnaw said at Davos.
Sun Pharma Gets DCGI Nod for Generic Wegovy, Set for March Launch as Semaglutide Patent Nears Expiry
By Axel Miller | 23 Jan 2026
Sun Pharma has received DCGI approval for generic semaglutide for weight management and will launch Noveltreat after the semaglutide patent expires in March 2026.
Indus Towers to Set Up GIFT City Hub to Centralise Global Expansion Plans
By Cygnus | 22 Jan 2026
Indus Towers will set up a wholly owned subsidiary in GIFT City to act as a holding and treasury hub for its overseas expansion after creating units in Nigeria, Zambia and Uganda.
NATO Commander Warns Russia-China Arctic Push Is a ‘Front Line’ as Greenland Tensions Ease
By Cygnus | 22 Jan 2026
NATO commander Gen. Alexus Grynkewich warned the Arctic is becoming a strategic front line as Russia and China expand joint patrols and undersea mapping amid Greenland tensions.
US Formally Exits World Health Organization as Unpaid Dues Dispute Triggers Geneva Budget Shock
By Axel Miller | 22 Jan 2026
The US has formally exited the WHO on Jan 22, 2026, triggering a budget shock in Geneva as a dues dispute over $260 million raises legal and diplomatic questions.
Sony–TCL TV Joint Venture: Redefining the Bravia Era
By Cygnus | 22 Jan 2026
Sony and TCL signed an MoU to form a TV joint venture, with TCL holding 51% control and Sony retaining 49%, signalling a major reshaping of the Bravia era.
